Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.
Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients.
Substance Name: MEDI 551
Metals and Neurodegeneration.
The risk of smoking on multiple sclerosis: a meta-analysis based on 20,626 cases from case-control and cohort studies.
Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient.
Expression and activation of human endogenous retroviruses of the W family in blood cells and astrocytes: implications for the pathogenesis of multiple sclerosis.
Perceived impact of spasticity is associated with spatial and temporal parameters of gait in multiple sclerosis.
Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS.
Cognitive rehabilitation correlates with the functional connectivity of the anterior cingulate cortex in patients with multiple sclerosis.
Cine cerebrospinal fluid imaging in multiple sclerosis.
Fatigue and Depression in Children With Demyelinating Disorders.
Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
Symptoms, Prevalence and Impact of Multiple Sclerosis in Younger Patients: A Multinational Survey.
Association between parasite infection and immune responses in multiple sclerosis.
Cannabinoids in the management of difficult to treat pain.
Natalizumab-induced autoimmune hepatitis in a patient with multiple sclerosis.
[HTLV-1-associated myelopathy/tropical spastic paraparesis : A differential diagnosis in multiple sclerosis.]
[Neuromyelitis optica spectrum disorder: a case report].
The effect of gabapentin on oxidative stress in a model of toxic demyelination in rat brain.
Multiple sclerosis shrinks intralesional, and enlarges extralesional, brain parenchymal veins.
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper.
[Physical rehabilitation in multiple sclerosis: general principles and high-tech approaches].
Extracellular O-linked β-N-acetylglucosamine: Its biology and relationship to human disease.
Pages
« first
‹ previous
…
208
209
210
211
212
213
214
215
216
…
next ›
last »